{{Rsnum
|rsid=2835265
|Gene=CBR1
|Chromosome=21
|position=36072398
|Orientation=plus
|GMAF=0.1313
|Gene_s=CBR1,LOC100133286
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 79.6 | 19.5 | 0.9
| HCB | 63.7 | 32.6 | 3.7
| JPT | 46.0 | 46.0 | 8.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 63.7 | 32.6 | 3.7
| CHD | 70.6 | 24.8 | 4.6
| GIH | 64.0 | 35.0 | 1.0
| LWK | 93.5 | 6.5 | 0.0
| MEX | 69.0 | 24.1 | 6.9
| MKK | 98.7 | 1.3 | 0.0
| TSI | 83.2 | 13.9 | 3.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=24330153
|Title=Host genome variations and risk of infections during induction treatment of childhood acute lymphoblastic leukaemia
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}